Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-3 of 3 (Search time: 0.001 seconds).
  • previous
  • 1
  • next
Item hits:
Publication DateTitleAuthor(s)TypeSubject
24-May-202010-Valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine (PHiD-CV10) versus 13-valent pneumococcal conjugate vaccine (PCV13) as a booster dose to broaden and strengthen protection from otitis media (PREVIX_BOOST) in Australian Aboriginal children: study protocol for a randomised controlled trial.Oguoma VM; Wilson N; Mulholland K; Santosham M; Torzillo P; McIntyre P; Smith-Vaughan H; Balloch A; Chatfield M; Lehmann D; Binks MJ; Chang A; Carapetis JR; Krause VL; Andrews RM; Snelling T; Licciardi P; Morris PS; Leach AJJournal Article-
2018The NICE-GUT trial protocol: a randomised, placebo controlled trial of oral nitazoxanide for the empiric treatment of acute gastroenteritis among Australian Aboriginal children.Waddington CS; McLeod C; Morris PS; Bowen AC; Naunton M; Carapetis J; Grimwood K; Robins-Browne R; Kirkwood CD; Baird RW; Green D; Andrews RM; Fearon D; Francis JR; Marsh JA; Snelling TJournal ArticleBayesian inference; cryptosporidium; diarrhoea; gastrointestinal infections; nitazoxanide
16-Jan-2015Pneumococcal conjugate vaccines PREVenar13 and SynflorIX in sequence or alone in high-risk Indigenous infants (PREV-IX_COMBO): protocol of a randomised controlled trial.Leach AJ; Mulholland EK; Santosham M; Torzillo PJ; Brown NJ; McIntyre P; Smith-Vaughan H; Skull S; Balloch A; Andrews RM; Carapetis J; McDonnell J; Krause VL; Morris PSComparative Study; Journal Article; Randomized Controlled TrialIMMUNOLOGY; MICROBIOLOGY; PUBLIC HEALTH

Discover